Literature DB >> 11443188

Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11beta-hydroxylase) and CYP11B2(aldosterone synthase) cause steroid 11beta-hydroxylase deficiency and congenital adrenal hyperplasia.

S Portrat1, P Mulatero, K M Curnow, J L Chaussain, Y Morel, L Pascoe.   

Abstract

Chromosomal rearrangements are natural experiments that can provide unique insights into in vivo regulation of genes and physiological systems. We have studied a patient with congenital adrenal hyperplasia and steroid 11beta-hydroxylase deficiency who was homozygous for a deletion of the CYP11B1 and CYP11B2 genes normally required for cortisol and aldosterone synthesis, respectively. The genes were deleted by unequal recombination between the tandemly arranged CYP11B genes during a previous meiosis, leaving a single hybrid gene consisting of the promoter and exons 1-6 of CYP11B2 and exons 7-9 of CYP11B1. The hybrid gene also carried an I339T mutation formed by intracodon recombination at the chromosomal breakpoint. The mutant complementary DNA corresponding to this gene was expressed in COS-1 cells and was found to have relatively unimpaired 11beta-hydroxylase and aldosterone synthase activities. Apparently the 11beta-hydroxylase deficiency and the adrenal hyperplasia are due to the lack of expression of this gene in the adrenal zona fasciculata/reticularis resulting from replacement of the CYP11B1 promoter and regulatory sequences by those of CYP11B2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443188     DOI: 10.1210/jcem.86.7.7671

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Progress in molecular-genetic studies on congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency.

Authors:  Li-Qiang Zhao; Su Han; Hao-Ming Tian
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

Review 2.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

3.  Improving the diagnosis of 11β-hydroxylase deficiency using home-made MLPA probes: identification of a novel chimeric CYP11B2/CYP11B1 gene in a Sicilian patient.

Authors:  S Menabò; S Boccassini; A Gambineri; A Balsamo; R Pasquali; O Prontera; L Mazzanti; L Baldazzi
Journal:  J Endocrinol Invest       Date:  2015-08-18       Impact factor: 4.256

Review 4.  Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach.

Authors:  María Arriba; Begoña Ezquieta
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-29       Impact factor: 5.555

Review 5.  Is There a Role for Genomics in the Management of Hypertension?

Authors:  Jacopo Burrello; Silvia Monticone; Fabrizio Buffolo; Martina Tetti; Franco Veglio; Tracy A Williams; Paolo Mulatero
Journal:  Int J Mol Sci       Date:  2017-05-26       Impact factor: 5.923

6.  A novel chimeric CYP11B2/CYP11B1 combined with a new p.L340P CYP11B1 mutation in a patient with 11OHD: case report.

Authors:  Lian Duan; Rufei Shen; Lingyu Song; Yong Liao; Hongting Zheng
Journal:  BMC Endocr Disord       Date:  2018-04-27       Impact factor: 2.763

Review 7.  The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy.

Authors:  Guyi Wang; Bing Xiao; Jiayi Deng; Linmei Gong; Yi Li; Jinxiu Li; Yanjun Zhong
Journal:  Front Pharmacol       Date:  2022-02-02       Impact factor: 5.810

8.  Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiency.

Authors:  Silvia Parajes; Lourdes Loidi; Nicole Reisch; Vivek Dhir; Ian T Rose; Rainer Hampel; Marcus Quinkler; Gerard S Conway; Lidia Castro-Feijóo; David Araujo-Vilar; Manuel Pombo; Fernando Dominguez; Emma L Williams; Trevor R Cole; Jeremy M Kirk; Elke Kaminsky; Gill Rumsby; Wiebke Arlt; Nils Krone
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

9.  A Novel Mutation in the CYP11B1 Gene Causes Steroid 11β-Hydroxylase Deficient Congenital Adrenal Hyperplasia with Reversible Cardiomyopathy.

Authors:  Mohammad A Alqahtani; Ayed A Shati; Minjing Zou; Ali M Alsuheel; Abdullah A Alhayani; Saleh M Al-Qahtani; Hessa M Gilban; Brain F Meyer; Yufei Shi
Journal:  Int J Endocrinol       Date:  2015-07-22       Impact factor: 3.257

10.  A Chinese patient with 11β-hydroxylase deficiency due to novel compound heterozygous mutation in CYP11B1 gene: a case report.

Authors:  Xianxian Yuan; Lin Lu; Shi Chen; Jun Jiang; Xiangqing Wang; Zhihui Liu; Huijuan Zhu; Hui Pan; Zhaolin Lu
Journal:  BMC Endocr Disord       Date:  2018-09-21       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.